PT  - JOURNAL ARTICLE
AU  - Riquelme, M.V.
AU  - Garner, E.
AU  - Gupta, S.
AU  - Metch, J.
AU  - Zhu, N.
AU  - Blair, M.F.
AU  - Arango-Argoty, G.
AU  - Maile-Moskowitz, A.
AU  - Li, A.
AU  - Flach, C-F
AU  - Aga, D.S.
AU  - Nambi, I.
AU  - Larsson, D.G.J.
AU  - Bürgmann, H.
AU  - Zhang, T.
AU  - Pruden, A.
AU  - Vikesland, P.J.
TI  - Wastewater Based Epidemiology Enabled Surveillance of Antibiotic Resistance
AID  - 10.1101/2021.06.01.21258164
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.06.01.21258164
4099  - http://medrxiv.org/content/early/2021/06/03/2021.06.01.21258164.short
4100  - http://medrxiv.org/content/early/2021/06/03/2021.06.01.21258164.full
AB  - Wastewater-based epidemiology (WBE) for disease monitoring is highly promising, but requires consistent methodologies that incorporate predetermined objectives, targets, and metrics. We demonstrate a comprehensive metagenomics-based approach for global surveillance of antibiotic resistance in sewage, enabling assessment of: 1) which antibiotic resistance genes (ARGs) are shared across regions/communities; 2) which ARGs are discriminatory; and 3) factors associated with overall trends including antibiotic concentrations in sewage. Across an internationally-sourced transect of sewage samples collected using a centralized, standardized protocol, ARG relative abundances (16S rRNA gene-normalized) were highest in Hong Kong and India and lowest in Sweden and Switzerland, reflecting national policy, measured antibiotic concentrations, and metal resistance genes. Asian versus European/US resistomes were distinct, with macrolide-lincosamide-streptogramin, phenicol, quinolone, and tetracycline versus multidrug resistance ARGs being discriminatory, respectively. Sales data were not predictive of antibiotics measured in sewage, emphasizing need for direct measurements. The WBE approach defined herein demonstrates multi-site comparability and sensitivity to local/regional factors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis material is based upon work supported by the U.S. National Science Foundation (NSF) Award OISE:1545756.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval was required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe wastewater influent metagenomic datasets have been deposited in NCBI Short Read Archive (SRA) under bioproject PRJNA527877.